Medical Professionals

There is a significant gap between the physician’s goal of sending patients for colorectal cancer screening, and the patient's desire to avoid complicated or cumbersome screening regimens. ColonSentry™ will help to address this gap. The test is a revolutionary advance with the potential to increase the detection of colorectal cancer 3-fold over existing practices through better patient compliance and better allocation of scarce colonoscopy resources.

ColonSentry makes testing for colorectal cancer as simple and convenient as the other blood tests performed at a patient's routine physical. The test assesses your patient’s current risk of having colorectal cancer. By adding this risk stratification tool as part of a regular health check-up, such as colonoscopy, individuals with increased risk can progress to further diagnostic testing where colorectal cancer can be identified in the early, treatable stages of the disease.

This section is designed to provide resources to help answer your questions and your patient’s questions about ColonSentry. If you have questions or would like further information on any of the reference materials discussed in these pages, we invite you to contact us at 905-739-2055 or toll-free at 1-877-GENENEWS (1-877-436-3639). You may also contact us at:
colonsentry@genenews.com



Enhancing Corporate Health and Wellness with ColonSentry

An effective colorectal cancer screening program saves lives and money. In addition to reducing mortality and morbidity, early colorectal cancer detection avoids significant financial costs including expensive treatment costs, long term disability, short term disability, employee absenteeism and life claims.

For information regarding using the ColonSentry test as part of your organization’s employee health and wellness program and promoting colorectal cancer screening education, please call 1-877-436-3639.

Please click here to read about how DundeeWealth is using the ColonSentry test to promote regular colorectal cancer screening and early colorectal cancer detection with its employees.
 
Links of London Tiffany Øredobber Pandora Jewelry